Tags

Type your tag names separated by a space and hit enter

The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population.
Diabetes Res Clin Pract. 2005 Mar; 67(3):251-7.DR

Abstract

To assess the prevalence of the metabolic syndrome disease cluster in the Hong Kong Chinese population we applied the US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) guidelines. This was present if > or =3 of the following conditions were present: Hypertension (> or =130/85 mmHg); fasting plasma glucose was > or =6.1 mmol/L; fasting plasma triglycerides > or =1.69 mmol/L; fasting HDL-cholesterol <1.04 or <1.29 mmol in males and females, respectively; or subjects were receiving treatment for their condition; waist circumference >88 or 102 cm (Asian WHO criteria > or =80 or 90 cm) in females and males, respectively. A total of 16.7% (17.1 (95%CI 15.7-18.5)% age and gender-adjusted) of the 2893 subjects had the metabolic syndrome. The prevalence of having at least 2, 3, 4 or 5 components was 34.5, 16.7, 6.4 and 1.4%, respectively. The prevalence increased from 3.1% in those aged 25-29 years to 41.0% in those aged over 70 years. Using the 2001 Census, 880,499 Hong Kong residents would have the metabolic syndrome. If the WHO recommended waist circumference for Asians is used, the age and gender-adjusted prevalence is significantly higher at 21.2% (21.9 (95%CI 20.4-23.4)%). In summary, the high prevalence of the metabolic syndrome in adult Hong Kong Chinese, particularly in the elderly, forewarns a rapidly increasing problem in Mainland China, and other Asian populations, which may have overwhelming public health ramifications.

Authors+Show Affiliations

Department of Community Medicine, 5/F Academic and Administration Block, Faculty of Medicine Building, University of Hong Kong, 21 Sassoon Road, Pokfulam, Hong Kong.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

15713358

Citation

Thomas, G Neil, et al. "The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) Prevalence of the Metabolic Syndrome in a Chinese Population." Diabetes Research and Clinical Practice, vol. 67, no. 3, 2005, pp. 251-7.
Thomas GN, Ho SY, Janus ED, et al. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population. Diabetes Res Clin Pract. 2005;67(3):251-7.
Thomas, G. N., Ho, S. Y., Janus, E. D., Lam, K. S., Hedley, A. J., & Lam, T. H. (2005). The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population. Diabetes Research and Clinical Practice, 67(3), 251-7.
Thomas GN, et al. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) Prevalence of the Metabolic Syndrome in a Chinese Population. Diabetes Res Clin Pract. 2005;67(3):251-7. PubMed PMID: 15713358.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) prevalence of the metabolic syndrome in a Chinese population. AU - Thomas,G Neil, AU - Ho,Sai-Yin, AU - Janus,Edward D, AU - Lam,Karen S L, AU - Hedley,Anthony J, AU - Lam,Tai Hing, AU - ,, PY - 2004/07/19/received PY - 2004/07/20/revised PY - 2004/07/21/accepted PY - 2005/2/17/pubmed PY - 2005/5/11/medline PY - 2005/2/17/entrez SP - 251 EP - 7 JF - Diabetes research and clinical practice JO - Diabetes Res Clin Pract VL - 67 IS - 3 N2 - To assess the prevalence of the metabolic syndrome disease cluster in the Hong Kong Chinese population we applied the US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III) guidelines. This was present if > or =3 of the following conditions were present: Hypertension (> or =130/85 mmHg); fasting plasma glucose was > or =6.1 mmol/L; fasting plasma triglycerides > or =1.69 mmol/L; fasting HDL-cholesterol <1.04 or <1.29 mmol in males and females, respectively; or subjects were receiving treatment for their condition; waist circumference >88 or 102 cm (Asian WHO criteria > or =80 or 90 cm) in females and males, respectively. A total of 16.7% (17.1 (95%CI 15.7-18.5)% age and gender-adjusted) of the 2893 subjects had the metabolic syndrome. The prevalence of having at least 2, 3, 4 or 5 components was 34.5, 16.7, 6.4 and 1.4%, respectively. The prevalence increased from 3.1% in those aged 25-29 years to 41.0% in those aged over 70 years. Using the 2001 Census, 880,499 Hong Kong residents would have the metabolic syndrome. If the WHO recommended waist circumference for Asians is used, the age and gender-adjusted prevalence is significantly higher at 21.2% (21.9 (95%CI 20.4-23.4)%). In summary, the high prevalence of the metabolic syndrome in adult Hong Kong Chinese, particularly in the elderly, forewarns a rapidly increasing problem in Mainland China, and other Asian populations, which may have overwhelming public health ramifications. SN - 0168-8227 UR - https://www.unboundmedicine.com/medline/citation/15713358/The_US_National_Cholesterol_Education_Programme_Adult_Treatment_Panel_III__NCEP_ATP_III__prevalence_of_the_metabolic_syndrome_in_a_Chinese_population_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0168-8227(04)00261-X DB - PRIME DP - Unbound Medicine ER -